• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自转化生长因子βⅢ型受体的合成肽可抑制四氯化碳肝损伤大鼠的肝纤维化形成。

A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury.

作者信息

Ezquerro Ignacio-José, Lasarte Juan-José, Dotor Javier, Castilla-Cortázar Inma, Bustos Matilde, Peñuelas Iván, Blanco Gemma, Rodríguez Carlos, Lechuga Maria del Carmen G, Greenwel Patricia, Rojkind Marcos, Prieto Jesús, Borrás-Cuesta Francisco

机构信息

Departamento de Medicina Interna, Universidad de Navarra, Pamplona, Spain.

出版信息

Cytokine. 2003 Apr;22(1-2):12-20. doi: 10.1016/s1043-4666(03)00101-7.

DOI:10.1016/s1043-4666(03)00101-7
PMID:12946101
Abstract

Transforming growth factor beta1 (TGF-beta1) is a pleiotropic cytokine, which displays potent profibrogenic effects and is highly expressed in fibrotic livers. For this reason, development of TGF-B1 inhibitors might be of great importance to control liver fibrogenesis as well as other undesired side effects due to this cytokine. Potential peptide inhibitors of TGF-beta1 (derived from TGF-beta1 and from its type III receptor) were tested in vitro and in vivo using different assays. Peptides P11 and P12, derived from TGF-beta1, and P54 and P144, derived from its type III receptor, prevented TGF-beta1-dependent inhibition of MV1Lu proliferation in vitro and markedly reduced binding of TGF-beta1 to its receptors. P144 blocked TGF-beta1-dependent stimulation of a reporter gene under the control of human alpha2(I) collagen promoter. Intraperitoneal administration of P144 also showed potent antifibrogenic activity in vivo in the liver of rats receiving CCl4. These rats also showed a significant decrease in the number of activated hepatic stellate cells as compared with those treated with saline only. These results suggest that short synthetic peptides derived from TGF-beta1 type III receptor may be of value in reducing liver fibrosis in chronic liver injury.

摘要

转化生长因子β1(TGF-β1)是一种多效性细胞因子,具有强大的促纤维化作用,在纤维化肝脏中高度表达。因此,开发TGF-β1抑制剂对于控制肝纤维化以及该细胞因子引起的其他不良副作用可能非常重要。使用不同的试验在体外和体内对TGF-β1的潜在肽抑制剂(源自TGF-β1及其III型受体)进行了测试。源自TGF-β1的肽P11和P12以及源自其III型受体的P54和P144在体外可防止TGF-β1依赖性对MV1Lu增殖的抑制,并显著降低TGF-β1与其受体的结合。P144阻断了在人α2(I)胶原启动子控制下的报告基因的TGF-β1依赖性刺激。腹腔注射P144在接受四氯化碳的大鼠肝脏中也显示出体内强大的抗纤维化活性。与仅用盐水处理的大鼠相比,这些大鼠活化的肝星状细胞数量也显著减少。这些结果表明,源自TGF-β1 III型受体的短合成肽在减少慢性肝损伤中的肝纤维化方面可能具有价值。

相似文献

1
A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury.来自转化生长因子βⅢ型受体的合成肽可抑制四氯化碳肝损伤大鼠的肝纤维化形成。
Cytokine. 2003 Apr;22(1-2):12-20. doi: 10.1016/s1043-4666(03)00101-7.
2
Thymosin β4 suppresses CCl -induced murine hepatic fibrosis by down-regulating transforming growth factor β receptor-II.胸腺素 β4 通过下调转化生长因子 β 受体-Ⅱ抑制 CCl4 诱导的小鼠肝纤维化。
J Gene Med. 2018 Sep;20(9):e3043. doi: 10.1002/jgm.3043. Epub 2018 Aug 15.
3
Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.腺病毒介导的与转化生长因子-β1的3'编码序列互补的反义RNA可抑制肝星状细胞的纤维化活性。
Cell Growth Differ. 2002 Jun;13(6):265-73.
4
A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats.转化生长因子-β₁ 型 III 受体的合成肽可抑制 NADPH 氧化酶并预防自发性高血压大鼠肾脏的氧化应激。
Antioxid Redox Signal. 2013 Nov 10;19(14):1607-18. doi: 10.1089/ars.2012.4653. Epub 2013 Mar 18.
5
Ginkgo biloba extract alleviates liver fibrosis induced by CCl in rats.银杏叶提取物可减轻四氯化碳诱导的大鼠肝纤维化。
Liver Int. 2005 Dec;25(6):1224-32. doi: 10.1111/j.1478-3231.2005.01169.x.
6
In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis.可溶性转化生长因子βⅡ型受体对大鼠星状细胞激活的体内抑制作用:肝纤维化的一种潜在新疗法。
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12719-24. doi: 10.1073/pnas.96.22.12719.
7
Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats.转化生长因子βⅡ型受体在肝纤维化中的作用:人类慢性丙型肝炎及大鼠实验性肝纤维化研究
Hepatology. 1999 Jun;29(6):1730-8. doi: 10.1002/hep.510290622.
8
Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3.奥美沙坦和欧米伽-3 对四氯化碳诱导的肝氧化应激、损伤和纤维化的调节作用。
Chem Biol Interact. 2014 Jan 25;207:81-91. doi: 10.1016/j.cbi.2013.10.008. Epub 2013 Oct 18.
9
Transforming growth factor-beta gene expression in normal and fibrotic rat liver.
J Hepatol. 1997 Apr;26(4):886-93. doi: 10.1016/s0168-8278(97)80257-7.
10
Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.乙醛刺激潜伏转化生长因子-β1的激活,并诱导大鼠培养的肝星状细胞中细胞因子II型受体的表达。
Biochem J. 2002 Dec 15;368(Pt 3):683-93. doi: 10.1042/BJ20020949.

引用本文的文献

1
Exploring the Therapeutic Potential of TGF-β Inhibitors for Liver Fibrosis: Targeting Multiple Signaling Pathways.探索TGF-β抑制剂对肝纤维化的治疗潜力:靶向多种信号通路
J Clin Transl Hepatol. 2025 Jul 28;13(7):588-598. doi: 10.14218/JCTH.2025.00029. Epub 2025 Jul 15.
2
Structures of TGF-β with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling.转化生长因子-β(TGF-β)与β-聚糖及信号受体的结构揭示了复合物组装和信号传导机制。
Nat Commun. 2025 Feb 26;16(1):1778. doi: 10.1038/s41467-025-56796-9.
3
Peptide discovery across the spectrum of neuroinflammation; microglia and astrocyte phenotypical targeting, mediation, and mechanistic understanding.
神经炎症全谱中的肽发现;小胶质细胞和星形胶质细胞表型靶向、介导及机制理解。
Front Mol Neurosci. 2024 Nov 20;17:1443985. doi: 10.3389/fnmol.2024.1443985. eCollection 2024.
4
TGF-β signaling in health, disease, and therapeutics.TGF-β 信号在健康、疾病和治疗中的作用。
Signal Transduct Target Ther. 2024 Mar 22;9(1):61. doi: 10.1038/s41392-024-01764-w.
5
Assessment of the effectiveness of the peptide inhibitor homologous to the transforming growth factor β cytokine blocking the TGFβRI/TGFβRII receptor complex-pilot study.评估与转化生长因子β细胞因子同源的肽抑制剂阻断TGFβRI/TGFβRII受体复合物的有效性——初步研究
Clin Transl Allergy. 2024 Jan;14(1):e12320. doi: 10.1002/clt2.12320.
6
PET imaging with [Ga]-labeled TGFβ-targeting peptide in a mouse PANC-1 tumor model.在小鼠PANC - 1肿瘤模型中使用[镓]标记的靶向转化生长因子β(TGFβ)肽进行正电子发射断层扫描(PET)成像。
Front Oncol. 2023 Sep 15;13:1228281. doi: 10.3389/fonc.2023.1228281. eCollection 2023.
7
Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment.肿瘤微环境中靶向调节性 T 细胞的药物偶联物:癌症治疗的制导导弹。
Exp Mol Med. 2023 Sep;55(9):1996-2004. doi: 10.1038/s12276-023-01080-3. Epub 2023 Sep 1.
8
TGF-β1 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophages.TGF-β1 肽基抑制剂 P144 通过调节交替激活的巨噬细胞改善缺血再灌注损伤后的肾纤维化。
Cell Prolif. 2022 Oct;55(10):e13299. doi: 10.1111/cpr.13299. Epub 2022 Jun 28.
9
P144 a Transforming Growth Factor Beta Inhibitor Peptide, Generates Antifibrogenic Effects in a Radiotherapy Induced Fibrosis Model.P144 a 转化生长因子β抑制剂肽,在放射诱导的纤维化模型中产生抗纤维化作用。
Curr Oncol. 2022 Apr 12;29(4):2650-2661. doi: 10.3390/curroncol29040217.
10
-2 Regulates Liver Fibrosis through the TGF-β Signaling Pathway.-2 通过转化生长因子-β信号通路调节肝纤维化。
Cancers (Basel). 2021 Oct 21;13(21):5279. doi: 10.3390/cancers13215279.